2022. Inhibition of IRAK 1/4 alleviates colitis by inhibiting TLR4/ NF-κB pathway and protecting the intestinal barrier. Biomolecules and Biomedicine. 22, 6 (Oct. 2022), 872–881. DOI:https://doi.org/10.17305/bjbms.2022.7348.